Xolair Interventional Study in ASD Patients With Comorbid Atopy
Stopped We are terminating due to loss of funding because of Covid-19.
Conditions
- Autism Spectrum Disorder
- Atopy
Interventions
- DRUG: Omalizumab Injection [Xolair]
Sponsor
Beth Israel Deaconess Medical Center
Collaborators